<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01048281</url>
  </required_header>
  <id_info>
    <org_study_id>GIUPR0001</org_study_id>
    <secondary_id>76274</secondary_id>
    <secondary_id>CA109190</secondary_id>
    <secondary_id>SU-11022007-787</secondary_id>
    <nct_id>NCT01048281</nct_id>
  </id_info>
  <brief_title>Clinical &amp; Pathological Studies of Upper Gastrointestinal Carcinoma</brief_title>
  <official_title>Clinical &amp; Pathological Studies of Upper Gastrointestinal Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      Our research of the biology of upper gastrointestinal cancers involves the study of tissue
      samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples
      from upper gastrointestinal cancer patients and persons at high inherited risk for these
      cancers. We hope to learn the role genes and proteins play in the development of gastric and
      esophageal cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2002</start_date>
  <completion_date type="Anticipated">January 2099</completion_date>
  <primary_completion_date type="Anticipated">January 2099</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>p53 activity by routine pathologic analysis</measure>
    <time_frame>time of collection</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NER activity by routine pathologic analysis</measure>
    <time_frame>time of collection</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stomach Cancer</condition>
  <condition>Gastro-Esophageal(GE) Junction Cancer</condition>
  <condition>Gastric (Stomach) Cancer</condition>
  <condition>Esophageal Cancer</condition>
  <condition>Gastrointestinal Stromal Tumor (GIST)</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood draw</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tissue tumor biopsy</intervention_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, tumor
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with gastric or esophageal cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:1. Over 18 2. Diagnosed with gastric or esophageal cancer OR at an
        increased hereditary risk for upper GI cancer

        Exclusion Criteria:1. Under 18 2. No family or personal history of gastric or esophageal
        cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James M Ford</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meredith Mills</last_name>
    <phone>(650) 724-5223</phone>
    <email>bluett@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meredith Mills</last_name>
      <phone>650-724-5223</phone>
      <email>bluett@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>James M Ford</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hanlee P. Ji</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vandana Bhardwaj Sharma</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2010</study_first_submitted>
  <study_first_submitted_qc>January 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2010</study_first_posted>
  <last_update_submitted>July 12, 2016</last_update_submitted>
  <last_update_submitted_qc>July 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

